GlassScriptPhysician profile
Michael W Escue
NPI 1871559955
$1,782.74
in general payments reported to CMS, 2019-2025
22 companies · $51.99 in 2025
The $51.99 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $161 · 2021: $566 · 2022: $298 · 2023: $267 · 2024: $283 · 2025: $51.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $601.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $483.51 | 2019-2022 | |
| Exeltis, USA INC. | $190.59 | 2021-2024 | Slynd |
| Organon LLC | $161.50 | 2022-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $110.27 | 2021-2023 | Novasure, Myosure Tissue Removal Device |
| Aspira Women'S Health INC | $96.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $94.12 | 2019-2023 | |
| Biogen, INC. | $93.52 | 2024 | Zurzuvae |
| Minerva Surgical, INC | $71.36 | 2021-2023 | |
| Astellas Pharma US INC | $67.38 | 2023-2024 | Veozah |
| Mayne Pharma Commercial LLC | $66.77 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $58.51 | 2019-2022 | |
| Applied Medical Resources Corporation | $48.01 | 2021 | |
| Ethicon US, LLC | $43.97 | 2024 | Enseal, Endopath Xcel, Surgicel Nu-Knit |
| Therapeuticsmd, INC. | $43.06 | 2019-2022 | |
| Davol INC. | $42.73 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $19.95 | 2019 | |
| Becton, Dickinson and Company | $19.12 | 2019 | |
| Avion Pharmaceuticals | $15.57 | 2022 | |
| Sumitomo Pharma America, INC. | $14.84 | 2024 | Myfembree |
| Novo Nordisk INC | $14.44 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $13.45 | 2019 | |
| Olympus America INC. | $13.38 | 2024 | 4k Cable 8.5m |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Escue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.